Navigation Links
InVivo Therapeutics and The Miami Project to Cure Paralysis Form Strategic Research Collaboration to Develop Novel Treatments for Spinal Cord Injuries
Date:5/4/2011

rd-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to sell additional shares of common stock and warrants to purchase common stock at additional closings, the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology in connection with spinal cord injuries; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies. These and other factors are identified and described in more detail in our filings with the SEC, including, our current reports on Form 10-K. We do not undertake to update these forward-looking statements made by us.Contacts:For Miami Project:

For InVivo Therapeutics:Scott Roy

Lauren MitarotondoThe Miami Project

InVivo Therapeutics305 243-8939

617-475-1518sroy@miami.edu

lmitarotondo@invivotherapeutics.com
'/>"/>

SOURCE The Miami Project; InVivo Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. invivodata and PRO Consulting to Present at International Industry Events
2. invivodata Announces ePROficiency 2009 Web Seminar Series
3. Quintiles Selects invivodata as Primary Partner for ePRO Solutions; Collaboration to Enhance Value, Effectiveness and Speed in Drug Development
4. invivodata Opens Registration for 3rd Annual Patient Reported Outcomes Conference
5. INC Research and invivodata Announce ePRO Partnership
6. invivodata Offers Complimentary PRO Gap Analysis
7. invivodata Delivers Critical Symptom Relief Data in INSYS Therapeutics' Breakthrough Cancer Pain Trial
8. invivodata Expands Spring Educational Program
9. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
10. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
11. Amsterdam Molecular Therapeutics Reports Half Year Results 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015 People with a common form of ... and sometimes profound improvements in their hearing and understanding ... a new multicenter study led by specialists at NYU ... online ahead of print in the journal The Laryngoscope July ... in the United States implanted ...
(Date:7/28/2015)... , July 21, 2015 Research and ... of the "Biomedical Refrigerators and Freezers Market ... and Forecast 2014 - 2022" report to ... refrigerators and freezers market has been segmented based ... blood banks, and others. The others segment includes ...
(Date:7/28/2015)... , July 28, 2015  Kerastem Technologies announce that ... the U.S. FDA Center For Biologics Evaluation and Research ... conduct a clinical trial investigating the safety and feasibility ... and early male pattern baldness (androgenic alopecia). ... follows initial clinical work in Europe ...
(Date:7/28/2015)... , July 28, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... that it has granted to German life sciences ... development and commercialization of biotechnology (collectively, the "Optionee"), ... oral allogenic tumor vaccine technology (the "Technology"), including ... cancer which is ready to enter a Phase ...
Breaking Biology Technology:Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 2Hybrid Cochlear Implants For Common Form Of Hearing Loss May Benefit Millions 3Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 3Kerastem Receives Conditional Approval from FDA for Alopecia Trial 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 3
... WOODLANDS, Texas , June 3 Lexicon Pharmaceuticals, ... discovering and developing breakthrough treatments for human disease, announced today that ... pharmaceutical research, will present at two investor conferences next week in ... Annual Needham Healthcare Conference on Wednesday, June 9, 2010 ...
... 3 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM), today ... newly created position of President and Chief Operating Officer. Dr. Glover ... for its operations and infrastructure, in particular the development and commercialization ... , ...
... CINCINNATI , June 3 Kendle (Nasdaq: ... (CRO), today announced it is ranked a top CRO to ... Kendle is the only CRO to be ranked consistently among ... years in the annual U.S. and European site surveys conducted ...
Cached Biology Technology:Lexicon to Present at Two Major Healthcare Investor Conferences 2Lexicon to Present at Two Major Healthcare Investor Conferences 3YM BioSciences appoints Dr. Nick Glover as President and Chief Operating Officer 2YM BioSciences appoints Dr. Nick Glover as President and Chief Operating Officer 3YM BioSciences appoints Dr. Nick Glover as President and Chief Operating Officer 4YM BioSciences appoints Dr. Nick Glover as President and Chief Operating Officer 5Kendle Rated a Top CRO to Work with for Fourth Consecutive Year 2Kendle Rated a Top CRO to Work with for Fourth Consecutive Year 3
(Date:7/21/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology from ... also the user using unique personal identifiers including ...
(Date:7/13/2015)... , July 13, 2015 Synaptics ... of human interface solutions, today announced sampling of ... and display driver integration (TDDI) product targeting smartphones ... first to combine Synaptics , best-in-class touch ... display driver technology developed in the company,s Japan ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... The American Physiological Society (APS; www.the-APS.org ) announced ... Fellowships to TanYa Gwathmey and Kesia Mathis. This is ... Gwathmey, an African-American, is a postdoctoral fellow in the ... University School of Medicine in Winston-Salem, N.C. There she ...
... previously-unreported callus hairs growing in the flesh of mature ... storage implications for commercial growers. To find out ... Mary Parker of the Institute of Food Research. Apples ... history and Fuji apples are particularly prized for their ...
... the launch of Bioscience Horizons, a unique peer-reviewed journal ... in the UK and Republic of Ireland. ... a collaboration between the universities of Leeds, Nottingham, Reading, ... to provide a forum for the brightest undergraduates in ...
Cached Biology News:APS names 2 minority outreach fellows 2APS names 2 minority outreach fellows 3Popular apple variety harbors unusual cell growth 2
The BD PhosFlow Fix Buffer I can be used for the simultaneous fixation and permeabilization of cells prior to intracellular staining. Applications: Intracellular Staining (Flow) Storage Temperature:...
Request Info...
Raised to 5-HIAA coupled to BSA with paraformaldehyde....
NuCycl DAPI Kit Application: Flow Cytometry Reactivity: Human...
Biology Products: